Researchers in the United Kingdom found that washing contaminated hospital bedsheets in a commercial washing machine with industrial detergent at high disinfecting temperatures failed to remove all traces of C. difficile, a bacteria that causes infectious diarrhea.
Over the last several flu seasons, coverage among children aged six months to 17 years has remained steady but fallen short of national public health goals, which are 80%.
CMS recently updated a memo to its survey teams on reducing the risk of Legionella to specifically note that facilities must have a water management plan that surveyors can review. That plan should be written and managed by a multidisciplinary committee of people from throughout the hospital with a stake in water use.
Published in the Society for Healthcare Epidemiology of America’s (SHEA) journal Infection Control & Hospital Epidemiology, the study points out that hospitals can do much more to reduce infections.
The FDA, which also rolled out a new antimicrobial resistance information page, is in talks with CMS and other agencies to develop this and other approaches to reduce antimicrobial resistance.
The Legionella bacterium is responsible for legionellosis: a respiratory disease that can cause a type of pneumonia called Legionnaires’ disease, which kills about a quarter of the people who contract it.
During the week of September 17-21, SHEA and its partners will lead activities and provide tips and information on a variety of infection prevention-related topics.
Effective as of September 1, the revisions are meant to hone in on the process steps that pose the highest risk to patients.
An October 2017 study in Open Forum Infectious Diseases, “Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study,” found that from 2011 to 2014, instances of community-associated C. diff infections in the U.S. grew from 35% of all C. diff infections to 41%.
Public Citizen claims the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) trial is dangerous because patients are being given one of two treatments for sepsis, both of which are risky and neither of which is considered standard treatment.